European Union governments have agreed to exercise an option to buy over 180 million doses of a version of the COVID-19 vaccine adapted for the Omicron variant developed by BioNTech and Pfizer, the head of the European Commission said.
from CBC | Health News https://ift.tt/3F7KZo3
Aucun commentaire:
Enregistrer un commentaire